Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;18(5):552-562.
doi: 10.1038/ni.3713. Epub 2017 Mar 27.

Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

Affiliations

Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

Eliana Mariño et al. Nat Immunol. 2017 May.

Erratum in

Abstract

Gut dysbiosis might underlie the pathogenesis of type 1 diabetes. In mice of the non-obese diabetic (NOD) strain, we found that key features of disease correlated inversely with blood and fecal concentrations of the microbial metabolites acetate and butyrate. We therefore fed NOD mice specialized diets designed to release large amounts of acetate or butyrate after bacterial fermentation in the colon. Each diet provided a high degree of protection from diabetes, even when administered after breakdown of immunotolerance. Feeding mice a combined acetate- and butyrate-yielding diet provided complete protection, which suggested that acetate and butyrate might operate through distinct mechanisms. Acetate markedly decreased the frequency of autoreactive T cells in lymphoid tissues, through effects on B cells and their ability to expand populations of autoreactive T cells. A diet containing butyrate boosted the number and function of regulatory T cells, whereas acetate- and butyrate-yielding diets enhanced gut integrity and decreased serum concentration of diabetogenic cytokines such as IL-21. Medicinal foods or metabolites might represent an effective and natural approach for countering the numerous immunological defects that contribute to T cell-dependent autoimmune diseases.

PubMed Disclaimer

Comment in

References

    1. Nature. 2009 Oct 29;461(7268):1282-6 - PubMed
    1. Nature. 2008 Oct 23;455(7216):1109-13 - PubMed
    1. Nature. 2013 Dec 19;504(7480):446-50 - PubMed
    1. Eur J Immunol. 2006 Jul;36(7):1951-62 - PubMed
    1. Appl Environ Microbiol. 2006 Jul;72(7):5069-72 - PubMed